Targeting BRAF in metastatic colorectal cancer: Maximizing molecular approaches - ScienceDirect
PANDA study demonstrates progression-free survival gain for FOLFOX + panitumumab and 5FU / LV + first-line panitumumab to RAS-BRAF wild-type elderly metastatic colorectal cancer patients - Onco Americas
Cancers | Free Full-Text | Conversion Strategy in Left-Sided RAS/BRAF Wild- Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer | Nature Medicine
Immune checkpoint blockade therapy for BRAF mutant metastatic colorectal cancer: the efficacy, new strategies, and potential biomarkers | Discover Oncology
Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review - Benoist Chibaudel, Christophe Tournigand, Franck Bonnetain, Hubert Richa, Magdalena Benetkiewicz, Thierry André, Aimery de Gramont, 2015
![PDF] Colorectal Cancer Primary Tumor Location Implications on Biological Therapy in Metastatic Colorectal Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/50a4df542bd40adc614a990d8984a44bb22f05b5/3-Figure1-1.png "PDF] Colorectal Cancer Primary Tumor Location Implications on Biological Therapy in Metastatic Colorectal Cancer | Semantic Scholar")
PDF] Colorectal Cancer Primary Tumor Location Implications on Biological Therapy in Metastatic Colorectal Cancer | Semantic Scholar
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer | Cancer Cell International | Full Text
![PDF] Survival Outcomes in Patients With RAS Wild Type Metastatic Colorectal Cancer Classified According to Köhne Prognostic Category and BRAF Mutation Status | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/83d238981a0fb4261d1ccb37391284312cb0fd5e/2-Table1-1.png "PDF] Survival Outcomes in Patients With RAS Wild Type Metastatic Colorectal Cancer Classified According to Köhne Prognostic Category and BRAF Mutation Status | Semantic Scholar")
PDF] Survival Outcomes in Patients With RAS Wild Type Metastatic Colorectal Cancer Classified According to Köhne Prognostic Category and BRAF Mutation Status | Semantic Scholar
BRAF V600E and SRC mutations as molecular markers for predicting prognosis and conversion surgery in Stage IV colorectal cancer | Scientific Reports
IJMS | Free Full-Text | The Winding Roadmap of Biomarkers Toward Clinic: Lessons from Predictors of Resistance to Anti-EGFRs in Metastatic Colorectal Cancer
Kaplan-Meier curves for colorectal cancer patients with BRAF-wild-type... | Download Scientific Diagram
Overview of molecular biomarkers in metastatic colorectal cancer. WT,... | Download Scientific Diagram
Frequencies of RAS/BRAFV600E mutation subtypes. N = 152 (KRAS Exon2... | Download Scientific Diagram
Molecular targeted therapy of BRAF-mutant colorectal cancer - Michel Ducreux, Ali Chamseddine, Pierre Laurent-Puig, Cristina Smolenschi, Antoine Hollebecque, Peggy Dartigues, Emmanuelle Samallin, Valérie Boige, David Malka, Maximiliano Gelli, 2019
Contemporary treatment approaches for metastatic colorectal cancer driven by BRAF V600 mutations
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan | BMC Cancer | Full Text
Targeted Therapy for Colorectal Cancers With Non-V600 BRAF Mutations: Perspectives for Precision Oncology | JCO Precision Oncology
Frontiers | Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer
BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer | Modern Pathology
Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases - Harlid - 2022 - International Journal of Cancer - Wiley Online Library
Factors affecting treatment selection in RAS/BRAF wild-type... | Download Scientific Diagram
Colorectal Cancer – Treatments | Gastrointestinal Cancer
Cureus | Incidence of BRAF V600E Gene Mutation Among Lebanese Population in Melanoma and Colorectal Cancer: A Retrospective Study Between 2010 and 2019 | Article
BRAF mutation and clinical outcome in colon cancer. A-C. Kaplan-Meier... | Download Scientific Diagram
